Jeffrey Arcara

Corporate Officer/Principal en CORVUS PHARMACEUTICALS, INC. .

Fortuna: - $ al 30/04/2024

Health Technology

Consumer Services

Perfil

Jeffrey Arcara is currently the Chief Business Officer at Corvus Pharmaceuticals, Inc. He previously worked as the Vice President of Business Development at Neuromed Pharmaceuticals Ltd.
He received an undergraduate degree from the University of Wisconsin and an MBA from UCLA Anderson School of Management.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
CORVUS PHARMACEUTICALS, INC. -.--%	28/02/2024	0 ( -.--% )	- $	30/04/2024

Cargos activos de Jeffrey Arcara

Empresas	Cargo	Inicio
CORVUS PHARMACEUTICALS, INC.	Corporate Officer/Principal	06/02/2024

Todos los cargos activos de Jeffrey Arcara

Antiguos cargos conocidos de Jeffrey Arcara.

Empresas	Cargo	Fin
Neuromed Pharmaceuticals Ltd. Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC.	Corporate Officer/Principal	27/01/2010

Ver el detalle de la experiencia de Jeffrey Arcara.

Formación de Jeffrey Arcara.

University of Wisconsin	Undergraduate Degree
UCLA Anderson School of Management	Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jeffrey Arcara.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
CORVUS PHARMACEUTICALS, INC.	Health Technology

Empresas privadas	1
Neuromed Pharmaceuticals Ltd. Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC.	Health Technology